Profile data is unavailable for this security.
About the company
CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The Company conducts its businesses mainly in domestic market.
- Revenue in HKD (TTM)503.50m
- Net income in HKD-156.95m
- Incorporated2015
- Employees164.00
- LocationCStone Pharmaceuticals1000 Zhangheng Road Bldg 25Pudong New DistrictSUZHOU 200072ChinaCHN
- Phone+86 51 287186550
- Websitehttps://www.cstonepharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wuhan YZY Biopharma Co Ltd | 0.00 | -202.41m | 1.19bn | 114.00 | -- | 21.83 | -- | -- | -1.06 | -1.06 | 0.00 | 0.2821 | 0.00 | -- | -- | 0.00 | -83.99 | -- | -230.17 | -- | -- | -- | -- | -- | 1.21 | -44.35 | 0.7078 | -- | -- | -- | -1.50 | -- | -- | -- |
Hua Medicine | 120.15m | -290.48m | 1.21bn | 172.00 | -- | -- | -- | 10.10 | -0.2963 | -0.2963 | 0.1226 | -0.0373 | 0.0779 | 1.51 | 1.90 | 678,812.90 | -18.84 | -25.61 | -23.63 | -28.81 | 37.72 | -- | -241.76 | -1,654.70 | 4.64 | -- | 1.14 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
Mabpharm Ltd | 167.22m | -228.21m | 1.26bn | 347.00 | -- | 9.90 | -- | 7.52 | -0.0553 | -0.0553 | 0.0406 | 0.0308 | 0.164 | 0.1937 | 3.26 | 481,910.60 | -22.38 | -21.42 | -31.11 | -27.49 | 86.91 | -- | -136.47 | -486.40 | 0.6836 | -23.09 | 0.679 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
Frontage Holdings Corp | 2.03bn | 47.54m | 1.26bn | 1.66k | 26.96 | 0.4811 | 3.73 | 0.6229 | 0.023 | 0.023 | 0.9895 | 1.29 | 0.4701 | 56.23 | 4.18 | 1,152,014.00 | 1.06 | 4.46 | 1.30 | 5.28 | 28.56 | 34.00 | 2.26 | 9.92 | 1.25 | 2.19 | 0.311 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
Jacobio Pharmaceuticals Group Co Ltd | 25.57m | -399.12m | 1.33bn | 298.00 | -- | 1.34 | -- | 52.17 | -0.5142 | -0.5142 | 0.0329 | 1.26 | 0.016 | -- | 2.41 | 84,951.02 | -24.89 | -45.76 | -28.66 | -49.30 | 3.45 | -- | -1,560.88 | -372.22 | -- | -- | 0.1794 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
Immunotech Biopharm Ltd | 0.00 | -341.03m | 1.46bn | 211.00 | -- | 16.34 | -- | -- | -0.6627 | -0.6627 | 0.00 | 0.1738 | 0.00 | -- | -- | 0.00 | -35.21 | -37.42 | -55.75 | -45.48 | -- | -- | -- | -- | 0.3638 | -2.44 | 0.6119 | -- | -- | -- | -5.25 | -- | -8.46 | -- |
TOT Biopharm International Co Ltd | 1.07bn | 9.89m | 1.55bn | 551.00 | 146.72 | 1.94 | 22.07 | 1.44 | 0.0136 | 0.0136 | 1.48 | 1.03 | 0.6899 | 2.44 | 6.35 | 1,947,891.00 | 0.6356 | -20.01 | 0.8392 | -25.21 | 72.02 | 74.74 | 0.9212 | -68.53 | 1.63 | 2.98 | 0.3465 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
CARsgen Therapeutics Holdings Ltd | 6.99m | -766.37m | 1.75bn | 477.00 | -- | 1.07 | -- | 250.12 | -1.38 | -1.38 | 0.0126 | 2.87 | 0.0027 | -- | 0.302 | 13,550.88 | -29.27 | -- | -32.86 | -- | 25.50 | -- | -10,960.25 | -- | 9.44 | -- | 0.1246 | -- | -- | -- | 16.19 | -- | -- | -- |
Laekna Inc | 0.00 | -325.94m | 1.83bn | 92.00 | -- | 2.45 | -- | -- | -0.9147 | -0.9147 | 0.00 | 1.91 | 0.00 | -- | -- | 0.00 | -31.46 | -- | -35.71 | -- | -- | -- | -- | -- | -- | -- | 0.0856 | -- | -- | -- | 52.81 | -- | -- | -- |
ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 1.87bn | 145.00 | -- | 2.83 | -- | -- | -- | -- | -- | 1.77 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.14 | -- | -28.25 | -- | 5.82 | -- | -- | -- |
CStone Pharmaceuticals | 503.50m | -156.95m | 1.89bn | 164.00 | -- | 3.66 | -- | 3.75 | -0.1232 | -0.1232 | 0.3949 | 0.4016 | 0.2861 | 1.33 | 2.50 | 2,189,134.00 | -8.92 | -54.76 | -16.99 | -81.68 | 70.73 | -- | -31.17 | -301.62 | 1.45 | -- | 0.4171 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
Abbisko Cayman Ltd | 548.43m | -17.87m | 2.14bn | 275.00 | -- | 0.9283 | 587.33 | 3.90 | -0.0303 | -0.0303 | 0.8444 | 3.36 | 0.2159 | -- | -- | 2,125,706.00 | -0.7034 | -- | -0.733 | -- | 100.00 | -- | -3.26 | -- | -- | -- | 0.0142 | -- | -- | -- | 12.92 | -- | -- | -- |
Biocytogen Pharmaceuticals Beijng Co Ltd | 882.94m | -268.90m | 2.52bn | 1.04k | -- | 3.08 | -- | 2.85 | -0.6752 | -0.6752 | 2.22 | 2.04 | 0.3109 | 23.64 | 5.35 | 828,271.80 | -9.47 | -- | -12.44 | -- | 71.97 | -- | -30.46 | -- | 1.33 | -3.22 | 0.436 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
Alphamab Oncology | 282.19m | -237.81m | 2.56bn | 429.00 | -- | 1.43 | -- | 9.09 | -0.247 | -0.247 | 0.2931 | 1.86 | 0.1145 | 0.8256 | 13.94 | 648,721.30 | -9.65 | -18.72 | -11.16 | -21.94 | 79.33 | -- | -84.27 | -415.55 | 4.42 | -- | 0.167 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
Data as of Sep 23 2024. Currency figures normalised to CStone Pharmaceuticals's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 20.59m | 1.60% |
The Vanguard Group, Inc.as of 04 Sep 2024 | 17.85m | 1.39% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 8.70m | 0.68% |
Templeton Asset Management Ltd.as of 30 Aug 2024 | 8.21m | 0.64% |
Dimensional Fund Advisors LPas of 31 May 2024 | 352.00k | 0.03% |
Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 244.50k | 0.02% |
Ping An Fund Management Co., Ltd.as of 31 Dec 2023 | 147.50k | 0.01% |
SSgA Funds Management, Inc.as of 05 Sep 2024 | 127.50k | 0.01% |
Vanguard Global Advisers LLCas of 31 Aug 2024 | 59.00k | 0.01% |
Xinyuan Asset Management Co., Ltd.as of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 19 Sep 2024Source: FactSet Research Systems Inc.